Intriguingly, CXCL14 expression was observed to be restricted to the myoepithelial cells in ductal carcinoma in situ and the tumor epithelial cells in invasive breast carcinoma, suggesting CXCL14 might be converted into an autocrine factor from a paracrine factor [30]. Here, CXCL14 is linked to ductal breast carcinoma in situ.